文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

血清脂蛋白(a)水平可预测长期腹膜透析患者的主动脉僵硬度。

Serum Lipoprotein(a) Levels as a Predictor of Aortic Stiffness in Patients on Long-Term Peritoneal Dialysis.

机构信息

Division of Nephrology, Department of Internal Medicine, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Hualien, Taiwan.

Institute of Medical Sciences, Tzu Chi University, Hualien, Taiwan.

出版信息

Med Sci Monit. 2024 Jun 5;30:e944348. doi: 10.12659/MSM.944348.


DOI:10.12659/MSM.944348
PMID:38835156
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11163936/
Abstract

BACKGROUND Lipoprotein (a) [Lp(a)] is associated with atherosclerosis and cardiovascular mortality in patients with kidney failure. Aortic stiffness (AS), measured primarily by carotid-femoral pulse wave velocity (cfPWV), reflects vascular aging and precedes end-organ failure. This study aimed to evaluate the association between serum Lp(a) levels and cfPWV in patients undergoing peritoneal dialysis (PD). MATERIAL AND METHODS In this cross-sectional study, which included 148 patients with long-term PD for end-stage kidney failure, cfPWV was measured using a cuff-based method. AS was defined as a cfPWV exceeding 10 m/s, and an enzyme-linked immunosorbent assay was used to determine serum Lp(a) levels. Univariate and multivariate regression analyses were performed to identify the clinical correlates of AS. RESULTS There were 32 (21.6%) patients diagnosed with AS. Based on the multivariate logistic regression analysis, the odds ratio for AS was 1.007 (95% confidence interval, 1.003-1.011; P=0.001) for every 1 mg/L increase in Lp(a) levels. Multivariate linear regression analysis showed that Lp(a) (P<0.001), age (P=0.003), waist circumference (P=0.008), systolic blood pressure (P=0.010), and diabetes mellitus (P<0.001) were positively associated with cfPWV. The area under the receiver operating characteristic curve for Lp(a) in differentiating AS from non-AS was 0.770 (95% confidence interval, 0.694-0.835; P<0.0001). CONCLUSIONS Serum Lp(a) level was independently associated with cfPWV and AS in patients with PD.

摘要

背景:脂蛋白(a)[Lp(a)]与肾衰竭患者的动脉粥样硬化和心血管死亡率相关。主动脉僵硬度(AS)主要通过颈股脉搏波速度(cfPWV)来测量,反映血管老化,并先于终末器官衰竭。本研究旨在评估接受腹膜透析(PD)的患者血清 Lp(a)水平与 cfPWV 之间的关系。

材料与方法:在这项包括 148 名长期肾衰竭接受 PD 治疗的患者的横断面研究中,使用基于袖带的方法测量 cfPWV。AS 定义为 cfPWV 超过 10m/s,采用酶联免疫吸附试验测定血清 Lp(a)水平。进行单变量和多变量回归分析以确定 AS 的临床相关因素。

结果:有 32 名(21.6%)患者被诊断为 AS。基于多变量逻辑回归分析,Lp(a)每增加 1mg/L,AS 的比值比为 1.007(95%置信区间,1.003-1.011;P=0.001)。多变量线性回归分析表明,Lp(a)(P<0.001)、年龄(P=0.003)、腰围(P=0.008)、收缩压(P=0.010)和糖尿病(P<0.001)与 cfPWV 呈正相关。Lp(a)区分 AS 与非 AS 的受试者工作特征曲线下面积为 0.770(95%置信区间,0.694-0.835;P<0.0001)。

结论:血清 Lp(a)水平与 PD 患者的 cfPWV 和 AS 独立相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32c/11163936/0c43a8415f0a/medscimonit-30-e944348-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32c/11163936/0c43a8415f0a/medscimonit-30-e944348-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c32c/11163936/0c43a8415f0a/medscimonit-30-e944348-g001.jpg

相似文献

[1]
Serum Lipoprotein(a) Levels as a Predictor of Aortic Stiffness in Patients on Long-Term Peritoneal Dialysis.

Med Sci Monit. 2024-6-5

[2]
Serum osteoprotegerin is an independent marker of central arterial stiffness as assessed using carotid-femoral pulse wave velocity in hemodialysis patients: a cross sectional study.

BMC Nephrol. 2019-5-23

[3]
Serum Endocan Is a Risk Factor for Aortic Stiffness in Patients Undergoing Maintenance Hemodialysis.

Medicina (Kaunas). 2024-6-14

[4]
Positive Association of Serum Galectin-3 with the Development of Aortic Stiffness of Patients on Peritoneal Dialysis.

J Clin Med. 2023-5-17

[5]
Serum leptin levels are positively associated with aortic stiffness in patients with chronic kidney disease stage 3-5.

Adipocyte. 2020-12

[6]
Serum Sclerostin But Not DKK-1 Correlated with Central Arterial Stiffness in End Stage Renal Disease Patients.

Int J Environ Res Public Health. 2020-2-14

[7]
Arterial Stiffness as a Predictor of the Index of Atherosclerotic Cardiovascular Disease in Hypertensive Patients.

Int J Environ Res Public Health. 2023-2-6

[8]
Serum Osteopontin Level Is Positively Associated with Aortic Stiffness in Patients with Peritoneal Dialysis.

Life (Basel). 2022-3-9

[9]
Associations of Glucometabolic Indices with Aortic Stiffness in Patients Undergoing Peritoneal Dialysis with and without Diabetes Mellitus.

Int J Mol Sci. 2023-12-4

[10]
Positive correlation of serum adipocyte fatty acid binding protein levels with carotid-femoral pulse wave velocity in geriatric population.

BMC Geriatr. 2015-7-24

引用本文的文献

[1]
Lipoprotein(a) Levels and Adverse Outcomes in Heart Failure.

J Card Fail. 2025-4-4

[2]
Association Between Lipoprotein(a) and Arterial Stiffness in Young Adults with Familial Hypercholesterolemia.

J Clin Med. 2025-2-27

[3]
Klotho enhances stability of chronic kidney disease atherosclerotic plaques by inhibiting GRK2/PLC-β-mediated endoplasmic reticulum stress in macrophages via modulation of the ROS/SHP1 pathway.

Sci Rep. 2024-12-30

本文引用的文献

[1]
Serum Albumin Levels: A Biomarker to Be Repurposed in Different Disease Settings in Clinical Practice.

J Clin Med. 2023-9-17

[2]
Lipoprotein(a) is associated with a larger systemic burden of arterial calcification.

Eur Heart J Cardiovasc Imaging. 2023-7-24

[3]
Lipoprotein(a) in Atherosclerotic Diseases: From Pathophysiology to Diagnosis and Treatment.

Molecules. 2023-1-18

[4]
Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement.

Eur Heart J. 2022-10-14

[5]
Lipoprotein(a): An underestimated inflammatory mastermind.

Atherosclerosis. 2022-5

[6]
Lipoprotein(a) Induces Vesicular Cardiovascular Calcification Revealed With Single-Extracellular Vesicle Analysis.

Front Cardiovasc Med. 2022-1-28

[7]
Hospitalization in patients with dialysis in Taiwan: A nationwide population-based observational study.

J Formos Med Assoc. 2022-2

[8]
Plasma Lipoprotein(a) Levels as Determinants of Arterial Stiffening in Hypertension.

Biomedicines. 2021-10-20

[9]
Aortic Stiffness: Epidemiology, Risk Factors, and Relevant Biomarkers.

Front Cardiovasc Med. 2021-11-8

[10]
Association between body fat parameters and arterial stiffness.

Sci Rep. 2021-10-15

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索